Lidings held a series of webinars dedicated to the practical aspects of complying with the legislation on Critical Information Infrastructure (CII) security. 

On December 19, a major tax seminar titled "Taxes-2026" will be held in Moscow. This practical event, organized by the team of the Legal Masters Forum, is dedicated to the upcoming amendments to the Tax Code effective from 2026.

Lidings Managing Partner Andrey Zelenin will take part in the annual conference on law firm management: "The Future of the Legal Business in Russia. Strategy and Challenges of the Mid-2020s."

The event, supported by the Russian Arbitration Association (RAA), will unite the leadership of Russia's leading legal market players.

Partner and Head of the Lidings’ Intellectual Property practice Boris Malakhov will take part in an annual conference entitled Intellectual Property - 2025 organized by Pravo.ru. The conference will take place on 21 November 2025 in Baltschug Kempinski.

The final of the annual All-Russian competition for court battles and public speaking, the Kutafin Legal Cup, will be held on November 15 at the O.E. Kutafin Moscow State Law University (MSAL).

It is a particular honor for us to curate the Pharmaceutical Law track - an area in which we possess deep practical expertise.

On October 22nd, an online discussion will take place, focusing on the operations of Russian businesses in the Middle East and North Africa (MENA) countries under sanctions pressure. The event is organized by the Legal Insight magazine and the Russian Export Center.

Dmitry Kirillov, Partner, Head of Tax and Customs practice at Lidings, will moderate the discussion session "Disputes with Tax Authorities or Defense in Tax Disputes".

Alina Smakova, Lidings associate specializing in personal data protection issues, will speak on the topic "Cross-Border Transfer of Personal Data: Building Bridges, Not Walls. Organizing Legal Cross-Border Data Flows".

The forum "Localization in Manufacturing" will take place on September 18-19. The event is dedicated to the localization challenges faced by all Russian goods manufacturers since January 1, 2025, following the enactment of Government Decree No. 1875.

Lidings is pleased to invite you and your colleagues to a seminar on launching new drugs in the Russian market.

Regulatory incentives and objective economic realities are driving pharmaceutical companies to seek opportunities for launching new drugs. Such projects are now being conceived and implemented not only by innovative companies but also by players who have traditionally specialized in generics and biosimilars.

During our seminar, we will share our experience and propose effective, cost-efficient legal solutions to help businesses safely and promptly execute new launches at any stage.